dm+d

Unassigned

New Medicines

ATrynPre-eclampsia

Information

ATryn
Licence extension / variation
rEVO
rEVO

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Preeclampsia is a life-threatening condition that occurs in ~6-8% of all pregnancies. Around 0.15 - 0.2% of pregnancies in Western countries will be complicated by very early preterm preeclampsia [1]
27 February 2014Preeclampsia is a life-threatening condition that occurs in ~6-8% of all pregnancies. Around 0.15 - 0.2% of pregnancies in Western countries will be complicated by very early preterm preeclampsia [1]
Pre-eclampsia
Intravenous infusion